Damaged corneas were repaired at a Harvard teaching hospital in a unique clinical trial, reports New Atlas:

Since it's on the frontline of potential hazards from the outside world, the cornea features a population of limbal epithelial stem cells, which repair minor damage to keep the surface smooth and functional... The new study, conducted by scientists at Massachusetts Eye and Ear, investigated a new treatment called cultivated autologous limbal epithelial cells (CALEC). This involves removing stem cells from a patient's uninjured eye, growing their population in the lab for a few weeks, then surgically transplanting them into the injured eye.
The phase 1/2 trial recruited 14 patients to undergo the procedure, and followed them for 18 months afterwards... By the first checkup at three months, the corneas of seven (50%) of the participants had been completely restored. By the 12-month mark, that number had increased to 11 (79%) patients. Two other participants met the definition for partial success, so the team claims an overall success rate of 92% for CALEC.

[ Read more of this story ]( https://science.slashdot.org/story/25/03/09/1612213/stem-cell-therapy-trial-reverses-irreversible-damage-to-cornea?utm_source=atom1.0moreanon&utm_medium=feed ) at Slashdot.